Palo Alto, California – May 24, 2010, PREMIER Biosoft and Waters Corporation today announced a co-marketing agreement for providing data analysis solutions for research in glycomics. The collaboration with Waters will combine the strengths of both companies, and promises to benefit customers by delivering a more integrated solution for users.
According to Beth Gildea, Business Development Manager at Waters Corporation, "The discovery power of Waters' entire portfolio of LC/MS/MS products would be significantly extended by SimGlycan®."
To offer integrated workflow for glycobiology research, Waters Corporation will co-market PREMIER Biosoft’s SimGlycan®, an innovative high throughput MS/MS data analysis tool, for use with Waters' mass spectrometers, including the SYNAPT, Xevo, Quattro and ACQUITY series.
SimGlycan® is a data analysis tool that predicts glycan and glycopeptide structure using MS/MS data acquired by mass spectrometry. It matches the MS/MS spectra with its own comprehensive, robust and annotated database to predict glycan structure. A simple search generates a list of all the candidates close to the actual sample. Structures are scored using a proprietary algorithm to help judge the distinction between close matches. In addition, each structure is mined for associated class, reaction, pathway and enzyme, saving users their valuable time, money and the frustration of laborious manual annotation.
According to Kay Brown, Vice President (Business Development) at PREMIER Biosoft, "This collaboration will provide Waters customers a powerful tool to analyze and visualize their glycan and glycopeptide data."
For details, please visit: http://www.premierbiosoft.com/glycan/index.html
About PREMIER Biosoft International
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.premierbiosoft.com.
About Waters Corporation
Waters Corporation (NYSE:WAT) creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success. With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide. Additional information about Waters Corporation is available at http://www.waters.com.
Waters, UltraPerformance LC, UPLC, ACQUITY UPLC, ACQUITY, Synapt, Xevo are trademarks of Waters Corporation. SimGlycan is a trademark of Premier Biosoft.
PREMIER Biosoft International
Brian J. Murphy
Public Relations Manager